Kwb Wealth Abbott Laboratories Transaction History

Kwb Wealth

$734 Million
Q2 2024

A detailed history of Kwb Wealth transactions in Abbott Laboratories stock. As of the latest transaction made, Kwb Wealth holds 3,606 shares of ABT stock, worth $411,120. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,606

Previous 3,670 1.74%

Holding current value

$411,120

Previous $417,000 10.31%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $6,446 - $7,196	-64 Reduced 1.74%	3,606 $374,000
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $36,251 - $40,037	-331 Reduced 8.27%	3,670 $417,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $49,604 - $60,720	-550 Reduced 12.09%	4,001 $440,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $26,175 - $31,405	-274 Reduced 5.68%	4,551 $440,000
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $86,368 - $96,232	857 Added 21.6%	4,825 $526,000
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $950 - $1,115	10 Added 0.25%	3,968 $435,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $10,450 - $12,099	108 Added 2.81%	3,958 $383,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $49,810 - $60,204	488 Added 14.52%	3,850 $418,000
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $808 - $990	7 Added 0.21%	3,362 $473,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $50,980 - $56,399	437 Added 14.98%	3,355 $396,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $35,373 - $41,674	325 Added 12.53%	2,918 $350,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $272,265 - $296,691	2,593 New	2,593 $284,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kwb Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Kwb Wealth with notifications on news.

Account